AD reduced hyperglycemia, inhibited the development of oxidative stress, and was able to retard inflammation and apoptosis in diabetes by blocking the production of IL-18 and caspase 3 via the deregulation of NFkB expressions in the treated diabetic rats. This evidence concerns the gene NFKB1 and Hyperglycemia.